Multiple randomized trials in people with HIV-associated lipodystrophy support tesamorelin's approved use for reducing visceral abdominal fat. Trials reported reductions in visceral fat, increases in IGF-1, and fat reaccumulation after stopping treatment. Adverse events included injection-site reactions, arthralgia, and paresthesia. Evidence outside HIV-associated lipodystrophy remains limited.

Tesamorelin

GHRH analog studied for reducing visceral fat and supporting GH release.

About:

Tesamorelin is a growth-hormone-releasing hormone (GHRH) analog studied for its ability to stimulate the body’s own GH production. It is particularly researched for reducing visceral adipose tissue.

Growth HormoneLyophilized vial

What does this peptide do?

Clinical research examines its effects on body composition, lipid profiles, and the pulsatile release of growth hormone, distinguishing it from direct GH administration.

Reducing visceral fat

Trials report reduced visceral adipose tissue.

Supporting GH release

Stimulates the body's own pulsatile GH release.

Evidence grade

Highest evidence grade among the graded claims: A. Grades reflect study strength, not benefit.

What are the benefits and side effects of this peptide

What research says it may help with

Tesamorelin is a growth-hormone-releasing hormone (GHRH) analog studied for its ability to stimulate the body’s own GH production.
It is particularly researched for reducing visceral adipose tissue.
Research focus: Growth Hormone & Body Composition Clinical research examines its effects on body composition, lipid profiles, and the pulsatile release of growth hormone, distinguishing it from direct GH administration.

See the safety section. Absence of a flag is not evidence of safety.

A grade reflects evidence strength, not a recommendation to use this compound; a strong grade can attach to a harmful effect.

How to store this peptide

Lyophilized storage

Refrigerate at 2–8 °C in the original carton. Do not freeze.

Reconstituted storage

Once in use, may be kept below 30 °C for the period stated on the product label.

Storage Handling

Protect from light. Do not use if it has been frozen.

Draw the exact dose, every time

Peptide in vial

Bacteriostatic water added

Target dose

Draw to

10 units

Concentration

2,500 mcg/mL

Doses / vial

Vial lasts

140 days

This tool does the math from the values you enter. It does not recommend a dose. Always consult a qualified healthcare professional.

Related research

Peptide research hub

What Is Tesamorelin? A Straight Answer for Researchers

Peptide research hub

Sermorelin FDA 503A Status: What the Record Shows

Tesamorelin

What does this peptide do?

Evidence grade

What are the benefits and side effects of this peptide

How to store this peptide

Draw the exact dose, every time

Related research

Related peptides

Ipamorelin / CJC-1295

GHRP-6

Hexarelin